Skip to main content

						Joshua Boger
1379688
REPORT

Joshua Boger

QUICK FACTS
Date of Birth April 12, 1951
Age 71 years, 8 months, 8 days
Place of Birth Concord
Country
Profession Biochemist
Horoscope Aries

Joshua Boger Birthday Countdown

0 0 0
Days
:
0 0
Hours
:
0 0
Minutes
:
0 0
Seconds

Joshua Boger net worth, birthday, age, height, weight, wiki, fact 2022! In this article, we will discover how old is Joshua Boger? Who is Joshua Boger dating now & how much money does Joshua Boger have?

SHORT PROFILE
Father Not Available
Mother Not Available
Siblings Not Available
Spouse Not Known
Children(s) Not Available
[X]

Joshua Boger Biography

Joshua Boger is a famous Biochemist, who was born on April 12, 1951 in . Joshua S. Boger was born on April 12, 1951 in Concord, North Carolina to Charles E. Boger, Jr., a textile chemist and Mary Snead Boger, an actress and writer. According to Astrologers, Joshua Boger's zodiac sign is Aries.

Within 2 years, Boger was leading a group at Merck where he developed novel rational drug design techniques and applied them to pharmaceutical discovery and development. By 1987 Boger became senior director of basic chemistry at Merck Sharp & Dohme Research Laboratories, in charge of the departments of Biophysical Chemistry and Medicinal Chemistry of Immunology and Inflammation.

Boger then attended Harvard University, where he worked with Jeremy R. Knowles on the chemistry of cyclodextrin. He received his master’s degree in 1975 and doctorate degree in chemistry in 1979. He did postdoctoral research in molecular recognition with Jean-Marie Lehn from the Université Louis Pasteur in Strasbourg, France.

In 1989, Boger founded Vertex Pharmaceuticals Incorporated. He has served variously as its President, CEO and Chairman of the board.

Ethnicity, religion & political views

Many peoples want to know what is Joshua Boger ethnicity, nationality, Ancestry & Race? Let's check it out! As per public resource, IMDb & Wikipedia, Joshua Boger's ethnicity is Not Known. We will update Joshua Boger's religion & political views in this article. Please check the article again after few days.

Vertex also developed Telaprevir, a protease inhibitor for treatment of hepatitis C. Telaprevir works by disabling a protein that the virus requires for replication. Scientists at Vertex first published the crystal structure for the protease of the hepatitis C virus in 1996. As part of the development process for the drug, the company developed an elaborate systems biology model in which they modeled hepatitis C’s dynamics to the level of individual patient response. Telaprevir was approved by the Food and Drug Administration as Incivek in May 2011.

Joshua Boger Net Worth

Joshua is one of the richest Biochemist & listed on most popular Biochemist. According to our analysis, Wikipedia, Forbes & Business Insider, Joshua Boger net worth is approximately $1.5 Million.

Joshua Boger Net Worth & Salary
Net Worth $1.5 Million
Salary Under Review
Source of Income Biochemist
Cars Not Available
House Living in own house.

Joshua S. Boger (born April 12, 1951) is an organic chemist and the founder of Vertex Pharmaceuticals Incorporated. He is considered a pioneer in the field of structure-based rational drug design. Drugs developed include amprenavir, an HIV protease inhibitor; telaprevir, a protease inhibitor for treatment of hepatitis C; and Kalydeco, for the treatment of cystic fibrosis. In 2003, Vertex was listed as one of forty worldwide Technology Pioneers by the World Economic Forum. As of 2012, Boger became executive chairman of Alkeus Pharmaceuticals.

Vertex also developed Telaprevir, a protease inhibitor for treatment of hepatitis C. Telaprevir works by disabling a protein that the virus requires for replication. Scientists at Vertex first published the crystal structure for the protease of the hepatitis C virus in 1996. As part of the development process for the drug, the company developed an elaborate systems biology model in which they modeled hepatitis C’s dynamics to the level of individual patient response. Telaprevir was approved by the Food and Drug Administration as Incivek in May 2011.

Boger is an advocate of liberal education who has been strongly involved with his alma mater, Wesleyan University. Boger became a member of the board of trustees of Wesleyan University as of 1999, and chairman of the board of trustees as of 2009. On his retirement from the board of trustees in 2016, he and his family donated $20 million to Wesleyan, over half of which established an endowed scholarship program.

Joshua Boger Height

Joshua Boger's height Not available right now. Joshua weight Not Known & body measurements will update soon.
Joshua Boger Height & Body Stats
Height Unknown
Weight Not Known
Body Measurements Under Review
Eye Color Not Available
Hair Color Not Available
Feet/Shoe Size Not Available
From 1970 to 1973, Boger attended Wesleyan University. During this time Max Tishler, formerly the president of Merck Sharp and Dohme Research Laboratories, became Boger’s mentor. Boger received a bachelor’s degree in chemistry and philosophy from Wesleyan in 1973.

In 2000, Boger combined his interests in scuba diving and photography by photographing the coral reefs off Wakaya Island near Fiji. By 2014, he was showing his underwater photography in one-man gallery shows. A permanent exhibit of 22 photographs, “Wakaya Octocorals and Giants,” is on display at the Exley Science Center at Wesleyan University.

Who is Joshua Boger dating?

According to our records, Joshua Boger is possibily single & has not been previously engaged. As of May 2022, Joshua Boger’s is not dating anyone.

Relationships Record: We have no records of past relationships for Joshua Boger. You may help us to build the dating records for Joshua Boger!

While under Boger’s leadership, the company worked on several potentially valuable drug treatments. Agenerase (amprenavir), an HIV protease inhibitor, was co-developed by Vertex and GlaxoSmithKline for the treatment of HIV/AIDS and approved by the FDA in 1999. A second related drug was submitted for approval in 2002. Lexiva (fosamprenavir) was approved by U.S. regulators on October 20, 2003.

Facts & Trivia

Joshua Ranked on the list of most popular Biochemist. Also ranked in the elit list of famous celebrity born in . Joshua Boger celebrates birthday on April 12 of every year.

Boger is a founding director and chairman of NEHI (Network for Excellence in Health Innovation), established in 2002. He is a founding director and vice-chairman of the Alliance for Business Leadership (formerly the Progressive Business Leaders Network), established in 2006. Boger is a member of the board of fellows of the Harvard Medical School.

At Vertex, Boger pioneered an approach to structure-based rational drug design that changed the way that drug development occurred. The analogy often used for structure-based design is that of a lock and key: first understand the type of lock involved, and then design a key to fit that lock. Researchers sought to understand the structure of the molecules that might affect disease processes (the “lock”) and then to design drugs capable of interacting with the target molecules to alter their functions (the “key”). Employees worked in multi-disciplinary teams, combined technologies from biophysics, chemistry and computer science, and applied them to drug discovery and the development of small molecule drugs. As of 2003, Vertex was listed as one of forty worldwide Technology Pioneers by the World Economic Forum, for advancing drug discovery through this approach.

Boger retired as CEO of Vertex as of May 23, 2009, but remained on the Vertex Board of directors until June 2017. The history of Vertex has been chronicled by journalist Barry Werth in The Billion-Dollar Molecule (1995) and The Antidote.

In May 2012 Boger became executive chairman of Alkeus Pharmaceuticals. Alkeus is developing a possible drug treatment for Stargardt disease, a progressive genetic condition that is a major cause of juvenile macular degeneration.

You may read full biography about Joshua Boger from Wikipedia.